CVS Health Corp. planned insider sales
In the twelve months since 23 September 2025 insiders at CVS Health Corp. filed 3 Form 144 notices of planned sales, 74,631 shares worth $6.7 million at the time of filing, from 3 sellers. The latest, filed 22 May 2026: Aguirre Fernando (director), 2,263 shares worth $214,283, planned for around 20 May 2026 through TD Securities (USA) LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|
| 22 May 2026 | Aguirre Fernando | Director | 2,263 | $214,283 | 20 May 2026 | TD Securities (USA) LLC | Compensation | Form 144 |
| 21 May 2026 | Farah Roger N | Director | 2,817 | $263,886 | 21 May 2026 | Charles Schwab Corp. | Compensation | Form 144 |
| 8 May 2026 | Tilak Mandadi | Officer | 69,551 | $6.2 million | 8 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was. Value is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.
Source
Form 144 filings on EDGAR for CVS Health Corp.: the company's filing index, each notice read from its own XML.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.